Inspire Medical Systems, Inc. (INSP): Price and Financial Metrics

Inspire Medical Systems, Inc. (INSP): $238.00

-4.00 (-1.65%)

POWR Rating

Component Grades














  • INSP scores best on the Sentiment dimension, with a Sentiment rank ahead of 90.72% of US stocks.
  • INSP's strongest trending metric is Quality; it's been moving up over the last 177 days.
  • INSP's current lowest rank is in the Stability metric (where it is better than 9.17% of US stocks).

INSP Stock Summary

  • Price to trailing twelve month operating cash flow for INSP is currently 623.58, higher than 99.53% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 17.69, INSPIRE MEDICAL SYSTEMS INC has a higher such ratio than 93.92% of stocks in our set.
  • With a year-over-year growth in debt of -77.69%, INSPIRE MEDICAL SYSTEMS INC's debt growth rate surpasses merely 2.34% of about US stocks.
  • Stocks that are quantitatively similar to INSP, based on their financial statements, market capitalization, and price volatility, are FLYW, TBLA, DCBO, ROVR, and MNDY.
  • Visit INSP's SEC page to see the company's official filings. To visit the company's web site, go to

INSP Valuation Summary

  • In comparison to the median Healthcare stock, INSP's price/sales ratio is 276.6% higher, now standing at 17.7.
  • Over the past 60 months, INSP's EV/EBIT ratio has gone down 126.6.

Below are key valuation metrics over time for INSP.

Stock Date P/S P/B P/E EV/EBIT
INSP 2023-03-24 17.7 14.5 -160.7 -159.2
INSP 2023-03-23 16.8 13.8 -152.2 -150.2
INSP 2023-03-22 17.2 14.2 -156.6 -154.8
INSP 2023-03-21 17.7 14.6 -160.8 -159.3
INSP 2023-03-20 17.7 14.5 -160.6 -159.0
INSP 2023-03-17 17.6 14.5 -159.8 -158.2

INSP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INSP has a Quality Grade of C, ranking ahead of 29.59% of graded US stocks.
  • INSP's asset turnover comes in at 0.727 -- ranking 46th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows INSP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.727 0.854 -0.484
2021-06-30 0.638 0.852 -0.444
2021-03-31 0.490 0.849 -0.587
2020-12-31 0.466 0.847 -0.591
2020-09-30 0.433 0.847 -0.517
2020-06-30 0.406 0.841 -0.449

INSP Stock Price Chart Interactive Chart >

Price chart for INSP

INSP Price/Volume Stats

Current price $238.00 52-week high $282.31
Prev. close $242.00 52-week low $142.74
Day low $237.82 Volume 237,800
Day high $244.58 Avg. volume 312,984
50-day MA $254.02 Dividend yield N/A
200-day MA $219.49 Market Cap 6.93B

Inspire Medical Systems, Inc. (INSP) Company Bio

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company was founded in 2007 and is based in Maple Grove, Minnesota.

INSP Latest News Stream

Event/Time News Detail
Loading, please wait...

INSP Latest Social Stream

Loading social stream, please wait...

View Full INSP Social Stream

Latest INSP News From Around the Web

Below are the latest news stories about INSPIRE MEDICAL SYSTEMS INC that investors may wish to consider to help them evaluate INSP as an investment opportunity.

Inspire Medical Systems, Inc. (NYSE:INSP): When Will It Breakeven?

With the business potentially at an important milestone, we thought we'd take a closer look at Inspire Medical Systems...

Yahoo | March 22, 2023

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

Muslim Farooque on InvestorPlace | March 21, 2023

Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our first FDA approval in 2014, the research team at Mass Eye a

Yahoo | March 21, 2023

Inspire Medical Systems (INSP) Outperformed on 2023 Revenue Guidance

Alger Capital, an investment management company, released its “Alger Small Cap Focus Fund” fourth quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund underperformed the Russell 2000 Growth Index. The Energy and Communication Services sectors contributed to the fund’s relative performance in the quarter, while Consumer Discretionary […]

Yahoo | March 16, 2023

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium

MINNEAPOLIS, March 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received countrywide reimbursement approval in Belgium, effective immediately, at rates consistent with other countries around the world. “The healthcare team at Antwerp University Hospital (UZA) in

Yahoo | March 9, 2023

Read More 'INSP' Stories Here

INSP Price Returns

1-mo -9.78%
3-mo -5.51%
6-mo 34.18%
1-year -7.28%
3-year 294.82%
5-year N/A
YTD -5.51%
2022 9.48%
2021 22.31%
2020 153.46%
2019 75.64%
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7562 seconds.